This is a routine director-level liquidity event with no informational content. The identical block sizes and single-day execution point to a pre-arranged plan, not a bearish signal. Monitor for any C-suite selling or material changes in the business, but this filing alone warrants no action.
NVCR drugs
NVCR drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 4 $17.99entry
- T+1 · 6mo ago −4.61%α −2.02% · $17.16
- T+5 · 5mo ago −1.56%α +1.00% · $17.71
- T+20 · 4mo ago −4.39%α −3.02% · $17.20
- T+60 · 3mo ago −0.94%α −2.83% · $17.82
Price Chart
How similar events traded
Executive Summary
Seven NovoCure directors sold identical blocks of 2,945 shares each at $15.77 on June 2, 2026, for a total of $325K. The uniform size and timing suggest a pre-arranged plan or coordinated liquidity event rather than opportunistic selling. At 0.018% of market cap, the dollar value is trivial and not material.
Key Financial Metrics
Key Facts
- Seven directors each sold exactly 2,945 shares at $15.7707 on June 2, 2026
- Total open-market sales: $325,113
- Sales represent 0.018% of NVCR's $1.8B market cap
- No C-suite executives (CEO/CFO) participated in the sales
- Identical share amounts and same execution date strongly suggest a pre-arranged plan or tax-related transaction
Financial Impact
$325K in total insider sales, 0.018% of market cap
Risk Factors
- No material risk identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NVCR-1780520052321 |
Track record
20 reports on NVCR
5 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +19.75% at T+20 after the Feb 27, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $11.83 to $11.30 Now $11.30 −4.48% ▼ −4.48% −2.57% vs SPY
- Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
- Nov 9, 20267d ago 8-K Bearish 6/10 Entry $12.53 to $11.81 Now $11.30 +9.82% ▲ +5.75% +5.38% vs SPY
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $13.11 to $13.15 Now $11.30 −13.81% ▲ +0.31% +2.08% vs SPY
- Oct 1, 20266w ago 8-K Bullish 6/10 Entry $15.92 to $14.94 Now $11.30 −29.02% ▼ −6.16% −6.90% vs SPY
- Sep 9, 20269w ago 8-K Neutral 2/10 Entry $15.63 to $15.35 Now $11.30 −27.70% ▼ −1.79% −1.19% vs SPY
- Sep 1, 202610w ago 8-K Neutral 3/10 Entry $17.38 to $17.83 Now $11.30 −34.98% ▲ +2.59% +2.15% vs SPY
- Jul 23, 202616w ago 8-K Bullish 7/10 Entry $19.99 to $17.65 Now $11.30 −43.47% ▼ −11.71% −11.81% vs SPY
- Jun 30, 202619w ago 8-K Bullish 7/10 Entry $15.15 to $15.78 Now $11.30 −25.41% ▲ +4.16% +4.29% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers